Shinji Tanaka

21PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiologyMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 09, 2026
Current Status of Multidisciplinary Treatment Strategies for Hepatocellular Carcinoma in the Era of Advanced Systemic Therapies.

Keiichi Akahoshi, Shun Kaneko, Shinji Tanaka

|Dec 28, 2025
Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis.

Atsushi Nara, Shu Shimada, Yoshimitsu Akiyama

|Jun 12, 2025
PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer.

Kentaro Umemura, Yoshimitsu Akiyama, Shu Shimada

|May 27, 2025
Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases.

Fukiko Kawai-Kitahata, Yasuhiro Asahina, Sei Kakinuma

|Dec 10, 2024
Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer.

Shu Tsukihara, Yoshimitsu Akiyama, Shu Shimada

|Oct 02, 2023
Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease-related HCC.

Megumi Hatano, Yoshimitsu Akiyama, Shu Shimada

Pageof 4

Frequent Collaborators

6 joint publications

Shu Shimada

4 joint publications

Daisuke Ban

4 joint publications

Minoru Tanabe

3 joint publications

Keiichi Akahoshi